Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05120232 · ClinicalTrials.gov registry record · NA
Flourishing and Virtue in Cognitive-Behavioral Therapy for Anxiety and Depressive Disorders
A NA study of Anxiety Disorders and Depressive Disorder, sponsored by Boston University Charles River Campus.
- Completed
- Registry status
- NA
- Development phase
- 125
- Enrollment target
- 1
- Study location
NCT05120232 is a NA study of Anxiety Disorders and Depressive Disorder that has completed, run by Boston University Charles River Campus. The registered enrollment target is 125 participants, below the 1,138-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05120232, a NA study of Anxiety Disorders and Depressive Disorder, has completed, sponsored by Boston University Charles River Campus.
- COMPLETED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
This two phase study is testing an online version of a transdiagnostic, cognitive behavioral therapy, against a modified version of that therapy emphasizing positive affect. The first phase of the trial will focus on content development for the modified therapy and the second phase will be a randomized control trial comparing the two.
Conditions Studied
Interventions
- BEHAVIORAL Unified Protocol
- BEHAVIORAL Modified Unified Protocol (UP+)
Study Locations (1)
Massachusetts
- Center for Anxiety and Related Disorders - Boston University - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2021-03-08 |
| Est. Completion | 2024-01-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05120232
The ClinicalTrials.gov registry entry for NCT05120232 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,138-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (89% lower). The listed sponsor is Boston University Charles River Campus, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Anxiety Disorders appearing as the primary indexed condition, and to 2 interventions - of which Unified Protocol is the first listed.
NCT05120232 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05120232 about?
NCT05120232 is a clinical study titled "Flourishing and Virtue in Cognitive-Behavioral Therapy for Anxiety and Depressive Disorders". This two phase study is testing an online version of a transdiagnostic, cognitive behavioral therapy, against a modified version of that therapy emphasizing positive affect. The first phase of the trial will focus on content development for the modified therapy and the second phase will be a randomi...
What is the current status of trial NCT05120232?
This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2021-03-08. Estimated completion is 2024-01-16.
What conditions does trial NCT05120232 study?
This clinical trial studies the following conditions: Anxiety Disorders, Depressive Disorder.
What interventions are being tested in trial NCT05120232?
The interventions under investigation include: Unified Protocol (BEHAVIORAL), Modified Unified Protocol (UP+) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05120232?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05120232 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
Managing Anxiety in Pediatric Primary Care (MAPP)
RECRUITING · NA
-
DINO RCT - Treating Anxiety in Children With Autism
RECRUITING · NA
-
Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.